Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Idursulfase in Hunter Syndrome Patients <= 5 Years
NCT00607386Phase 4Completed
- Sponsor
- Takeda
- Start
- Dec 2007
- Primary completion
- Jul 2011
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of idursulfase in mucopolysaccharidosis type II, sponsored by Takeda. Started Dec 2007; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT00607386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607386.